Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,05 CAD | -2,38% | -0,49% | -24,07% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
William Radvak
FOU | Founder | 61 | 19/01/17 |
Michael Kelly
CEO | Chief Executive Officer | 59 | 10/04/23 |
Bill Adams
DFI | Director of Finance/CFO | 62 | 24/02/20 |
Daniel Mikol
CTO | Chief Tech/Sci/R&D Officer | - | 05/05/21 |
Adam Rogers
BRD | Director/Board Member | - | 14/07/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Randall Kaye
BRD | Director/Board Member | 62 | 28/10/20 |
Brian Bayley
BRD | Director/Board Member | 71 | 16/05/18 |
William Radvak
FOU | Founder | 61 | 19/01/17 |
Michael Kelly
CEO | Chief Executive Officer | 59 | 10/04/23 |
Harold Punnett
FOU | Founder | 67 | 19/01/17 |
John Thompson
BRD | Director/Board Member | 57 | 13/04/22 |
John Ruffolo
BRD | Director/Board Member | - | 17/10/23 |
Glenn Ives
BRD | Director/Board Member | 62 | 01/09/21 |
Adam Rogers
BRD | Director/Board Member | - | 14/07/22 |
Director/Board Member | - | 01/09/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 69 927 649 | 53 893 753 ( 77,07 %) | 0 | 77,07 % |
Coordinate società
NervGen Pharma Corp.
112-970 Burrard Street Unit 1290
V6Z 2R4, Vancouver
+778-731-1711
http://www.nervgen.comSettore
Vendite per regione
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-24,07% | 107 Mln | |
+0,67% | 42,19 Mrd | |
+44,30% | 40,15 Mrd | |
-6,20% | 28,31 Mrd | |
+6,55% | 24,63 Mrd | |
-21,66% | 18,2 Mrd | |
+29,96% | 12,01 Mrd | |
-1,57% | 11,76 Mrd | |
+16,03% | 10,4 Mrd | |
-4,80% | 9,94 Mrd |
- Borsa valori
- Azioni
- Azione NGEN
- Società NervGen Pharma Corp.